C1710261||Sustained delivery
C0042679||vincristine
C0574893||orthotopic
C1522023||mouse sarcoma
C1261473||Sarcoma
C0280100||solid tumors
C0543467||Surgery
C3665472||chemotherapy
C0027651||tumors
C1710261||sustained release
C0074529||silk
C0086418||Human
C0553580||Ewing sarcoma
C0334227||cells A673
C0430400||cultured
C0042679||vincristine
C0013089||doxorubicin
C0334227||Cells
C0025929||mouse
C1522391||hind leg
C0574893||orthotopic
C0027651||tumors
C0041618||ultrasound
C0184661||interventions
C0021107||implantation
C0074529||silk
C0013089||doxorubicin
C0013089||(Dox400
C0042679||vincristine
C0042679||Vin50
C0074529||silk
C0042679||vincristine
C0042679||Vin50
C0348016||intravenous
C0042679||vincristine
C0042679||Vin50
C0042679||vincristine
C0013089||doxorubicin
C0013089||Dox400
C0042679||Vin50
C4086857||slower growth
C0042679||Vin50
C0042679||Vin50
C4086857||Growth was slowest
C0042679||Vin50
C1710261||Sustained delivery
C0042679||vincristine
C1261473||sarcoma
C0027651||tumor
C0074529||silk
C1831733||intratumoral treatment
C0728940||surgical excision